Eagle Pharmaceuticals Competitors and Similar CompaniesClear all
Eagle Pharmaceuticals's competitors and similar companies include NewAmsterdam Pharma, AiCuris, Pathalys Pharma and European Medical Solutions.
 Eagle Pharmaceuticals Eagle Pharmaceuticals is a specialty pharmaceutical company, focusing on developing and commercializing injectable products primarily in the critical care and oncology areas. |  NewAmsterdam Pharma NewAmsterdam Pharma is a clinical-stage company focused on the research and development of transformative therapies for cardio-renal diseases. |  AiCuris AiCuris is a pharmaceutical company focusing on the discovery, research, and development of antiviral and antibacterial agents. |  Pathalys Pharma Pathalys Pharma is a clinical biopharmaceutical company that provides therapeutics development solutions. |  European Medical Solutions European Medical Solutions (formerly known as ASIT Biotech) is a clinical-stage biopharmaceutical company that focuses on the research, development, and commercialization of immunotherapy products for the treatment of allergies. | |
Founding Date | Founding Date 2007 | Founding Date 2019 | Founding Date 2006 | Founding Date 2021 | Founding Date 1997 |
Type | Type Public | Type Private | Type Private | Type Private | Type Subsidiary |
Tags | |||||
Locations | Locations Woodcliff Lake, US HQ Chicago, US | Locations Naarden, NL HQ | Locations Wuppertal, DE HQ Borken, DE | Locations Raleigh, US HQ Fujisawa, JP | Locations Liège, BE HQ Sint Lambrechts Woluwe, BE |
Employees | Employees 10813% increase | Employees 832% increase | Employees 731% increase | Employees 13 | Employees 2630% increase |
Financial | |||||
Revenue (est.) | Revenue (est.) $316.6m (FY, 2022) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) €49.9m (FY, 2025) |
Cost of goods | Cost of goods $85.5m (FY, 2022) | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A | Cost of goods €33.5m (FY, 2025) |
Gross profit | Gross profit $231.2m (FY, 2022) | Gross profit N/A | Gross profit N/A | Gross profit N/A | Gross profit €17.5m (FY, 2025) |
Net income | Net income $35.6m (FY, 2022) | Net income N/A | Net income N/A | Net income N/A | Net income €1.8m (FY, 2025) |
Funding | |||||
Latest funding round | Latest funding round N/A | Latest funding round $ 196m (over 5 years ago) | Latest funding round $ 74.8m (about 16 years ago) | Latest funding round $ 150m (over 3 years ago) | Latest funding round N/A |
Total funding raised | Total funding raised $ 12.3m | Total funding raised $ 196m | Total funding raised $ 74.8m | Total funding raised $ 150m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
NewAmsterdam Pharma
HQ
Naarden, NL
Employees
83↑ 2% increase
NewAmsterdam Pharma is a clinical-stage company focused on the research and development of transformative therapies for cardio-renal diseases.
View companyAiCuris
HQ
Wuppertal, DE
Employees
73↑ 1% increase
AiCuris is a pharmaceutical company focusing on the discovery, research, and development of antiviral and antibacterial agents.
View companyPathalys Pharma
HQ
Raleigh, US
Employees
13
Pathalys Pharma is a clinical biopharmaceutical company that provides therapeutics development solutions.
View companyEuropean Medical Solutions
HQ
Liège, BE
European Medical Solutions (formerly known as ASIT Biotech) is a clinical-stage biopharmaceutical company that focuses on the research, development, and commercialization of immunotherapy products for the treatment of allergies.
View company